🔎 Trials Near Me

Domov › Rak pljuč › Illinois › Cicero

Klinične študije za Rak pljuč v Cicero, IL

17 študij za Rak pljuč išče udeležence na lokacijah v Cicero in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • Edward Hines Jr VA Hospital, Hines · 4 mi stran
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi stran
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Vključevanje udeležencevFaza 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
Starost 70 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Vključevanje udeležencevFaza 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Hope and Healing Clinical Research, Hinsdale · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07476287

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Hope and Healing Cancer Services, Hinsdale · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Vključevanje udeležencevFaza 2
  • Hope and Healing Clinical Research, Hinsdale · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
  • Hope and Healing Cancer Services, Hinsdale · 10 mi stran
  • Endeavor Health, Elmhurst · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
  • Advocate High Tech Medical Park, Palos Heights · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi stran
  • Edward Hines Jr VA Hospital, Hines · 4 mi stran
  • Loyola University Medical Center, Maywood · 5 mi stran
  • in še 2
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

Vključevanje udeležencevOpazovalna študija
  • Affiliated Oncologists, LLC, Chicago Ridge · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 18. maj 2026 · NCT05885698

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Edward Hines Jr VA Hospital, Hines · 4 mi stran
  • Loyola University Medical Center, Maywood · 5 mi stran
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • Loyola University Medical Center, Maywood · 5 mi stran
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
  • in še 2
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Vključevanje udeležencev
  • Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 19. feb. 2026 · NCT02984761

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Vključevanje udeležencevOpazovalna študija
  • Advocate Christ Medical Center, Oak Lawn · 9 mi stran
  • Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 9. jan. 2026 · NCT06073431

Študije za Rak pljuč v drugih mestih

Druge študije v Cicero

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.